Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the close of its seed financing. The close brings total ...
In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...
Opinions expressed by Entrepreneur contributors are their own. It’s clich?; but true: your thoughts have a significant impact on your success and well-being. A study from the Harvard School of Public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results